The Role of Pharmacists in Optimizing Medication Regimens for Patients with Polypharmacy

Abstract

In order to maximise pharmaceutical regimens, reduce polypharmacy risks, and enhance patient outcomes, clinical chemists are in a unique position. Various facets of medication management fall under your purview, such as treatment, medication monitoring, and medication reconciliation. Clinical chemists and healthcare professionals work together to optimise prescription regimens, identify potential drug interactions, and customise treatment programs to meet the needs of each patient through collaborative practice agreements and interdisciplinary teamwork. Thus, there is compelling evidence to support the use of chemists in the provision of geriatric care to lessen polypharmacy and its clinical consequences, including hospitalisations, urgent or emergency room visits, medication errors, non-adherence, and adverse drug reactions. Due to the high rate of ADR recurrence, patients and the general public must bear a heavy financial burden and extended hospital stays. All social health professionals must collaborate to create clear and unambiguous evidence and, when necessary, report adverse drug reactions to pertinent intra-company, regional, or national surveillance authorities in order to lessen the impact and consequences of adverse drug reactions related to fear, mortality, and costs. To raise the frequency of adverse drug responses to medications, several nations have put in place pharmacovigilance programs. Voluntary ADR Reporting Systems (SADRRS) have also been expanded and implemented in a number of nations.